Chiara Rusconi

51PUBLICATIONS
246CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (51)

|Aug 05, 2026
Refining risk-stratification for mantle cell lymphoma: integrating novel combination treatments and personalized approaches.

|Jul 24, 2026
Molecular biomarkers as key determinants of outcome in mantle cell lymphoma: results from the FIL V-RBAC trial.

|Jul 14, 2026
Rituximab Maintenance Added to Ibrutinib-Containing Therapy in Younger, Untreated Patients With Mantle Cell Lymphoma: Results From the TRIANGLE Trial.

|Jun 26, 2026
BTK Degraders in Lymphoid Malignancies: New Modality, New Resistance Rules?

|Jun 17, 2026
Application of Hi-C sequencing to detect oncogene rearrangements for diagnosis and treatment of large B-cell lymphoma.

|May 05, 2026
Polatuzumab vedotin-containing regimens as bridge to CART: analysis from the CART-SIE study.

Pageof 9

Frequent Collaborators

8 joint publications

Francesca Maria Quaglia

7 joint publications

Luca Arcaini

7 joint publications

Michael Boe Møller

7 joint publications

Simone Ferrero